@kervio, thanks for your comments on this. I am also really shocked at the primary endpoint being set at a 43% improvement in mortality. I can't see how they would ever realistically have got overwhelming efficacy (e.g. using a sceptical prior) at any interim analysis if this was the goal.
I'm no expert at Bayesian analysis but I had a go at estimating some probability distributions for achieving various levels of mortality reduction for various observed deaths in the treatment arm at the 45% analysis stage (which obviously passed futility). I inferred some mean and standard deviations for both sceptical and enthusiastic priors under various scenarios. I have plotted these below for a particular scenario where 17 deaths were observed in the treatment arm and where there were theoretical deaths of 40.5 (i.e. mortality at 60%) in the control arm. This, I think, would be the 'worst case scenario' / maximum no of deaths that could have been observed at that the 45% stage for continuation of the trial. This also assumes NIH/MSB based futility analysis on an enthusiastic prior and selected 5% as the minimum required probability of achieving the endpoint.
If 17 deaths vs. 40.5 is in fact the worst case, that's still quite a treatment benefit!
- Forums
- ASX - By Stock
- Overwhelming efficacy - the stats required
@kervio, thanks for your comments on this. I am also really...
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.12 |
Change
-0.003(0.22%) |
Mkt cap ! $1.284B |
Open | High | Low | Value | Volume |
$1.14 | $1.16 | $1.12 | $1.070M | 942.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 74488 | $1.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.13 | 870 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 14665 | 1.125 |
14 | 74484 | 1.120 |
15 | 165660 | 1.115 |
18 | 324625 | 1.110 |
9 | 144490 | 1.105 |
Price($) | Vol. | No. |
---|---|---|
1.130 | 39241 | 11 |
1.135 | 55336 | 10 |
1.140 | 73556 | 9 |
1.145 | 125088 | 11 |
1.150 | 53537 | 7 |
Last trade - 10.28am 29/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |